EMORY UNIVERSITY

• LEIDOS BIOMEDICAL RESEARCH INC

  UEI HV8BH9BPG8Y9

  $2.4M

  Subcontractor to this prime · 2 sub-awards · latest Nov 30, 2023

  • National Institutes of Health
  • “MS7-CHRCT & CNFRM TESTING”
  • “MS1 DMID COVAIL OVERARCH”
• ACCESS TO ADVANCED HEALTH INSTITUTE

  UEI EMQ1ANLATYS6

  $1.2M

  Subcontractor to this prime · 1 sub-award · latest May 7, 2024

  • National Institutes of Health
  • “THIS STUDY WILL UTILIZE SYSTEMS IMMUNOLOGY APPROACHES TO INVESTIGATE THE IMMUNE SIGNATURES GENERATED BY OUR SARNA YFV VACCINE AND COMPARE THESE TO THE GOLD STANDARD YFV-17D LIVE-ATTENUATED VACCINE (YF-VAX). IMMUNE SIGNATURES WILL BE OBTAINED BY TRANSCRIPTOMIC ANALYSIS FOLLOWING PRIME AND BOOST IMMUNIZATIONS AND WILL CAPTURE BOTH EARLY INNATE AND ADAPTIVE IMMUNE SIGNATURES. IN ADDITION, WE WILL INVESTIGATE THE ANTIBODY REPERTOIRE GENERATED BY OUR VACCINE PLATFORM. WE WILL CORRELATE THESE SIGNATURES TO RESPONSE MEASURES OF CELLULAR AND HUMORAL IMMUNITY. CELLULAR IMMUNITY WILL FOCUS ON MARKERS OF MEMORY DEPOSITION FOR B CELLS (E.G., CD27) AND T CELLS AS A PRELIMINARY INDICATOR OF RESPONSE DURABILITY AND LONGEVITY.”
• ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  UEI C8H9CNG1VBD9

  $869.6K

  Subcontractor to this prime · 1 sub-award · latest Mar 18, 2024

  • National Institutes of Health
  • “OPTION 2: 0258-C504-4609 OPTION 3: 0258-D504-4609 OPTION 4: IF300302118-940002 OPTION 5: IF300302188-940002 THE WORK PERFORMED BY DR. MEDINA AND HIS COLLABORATORS WILL INCLUDE: 1. SURVEILLANCE OF HUMAN INFLUENZA VIRUS IN THE METROPOLITAN AREA OF SANTIAGO. 2. ENROLMENT OF HUMAN SUBJECTS UNDER AN APPROVED IRB PROTOCOL ALLOWING THE COLLECTION OF INFLUENZA CLINICAL SAMPLES AND METADATA. 3. COLLECTION OF 250 INFLUENZA CLINICAL SAMPLES FOR VIRUS ISOLATION AND TO ANALYZE IMMUNE RESPONSES. 4. ESTABLISHING A CLINICAL SAMPLE DATABASE. 5. CHARACTERIZATION (SUBTYPING) OF VIRAL STRAINS AND HOST IMMUNE RESPONSES DURING ACUTE INFECTION FROM 250 VIRAL SAMPLES OBTAINED FROM INDIVIDUALS. 6. SUBMITTING BI-MONTHLY, SEMI-ANNUAL AND ANNUAL CLINICAL PROGRESS REPORTS. 7. SURVEILLANCE OF SWINE INFLUENZA VIRUSES IN THE CENTRAL REGIONS OF CHILE. 8. CHARACTERIZATION OF SWINE VIRAL STRAINS AND GENOTYPES. 9. PERFORMING ANTIGENIC CHARACTERIZATION OF SELECTED ANIMAL STRAINS. 10. COLLABORATING AND EXCHANGING RESEARCH MATERIALS WITH MEMBERS OF THE CENTER. 11. ATTENDING THE CEIRS NETWORK ANNUAL MEETING. 12. ATTENDING SCIENTIFIC ADVISORY BOARD MEETINGS AND CLINICAL SITE VISITS.”
• TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE

  UEI GM1XX56LEP58

  $718.2K

  Subcontractor to this prime · 2 sub-awards · latest Apr 1, 2026

  • National Institutes of Health
  • “LAKDAWALA STATEMENT OF WORK IN THIS REVISED CEIRR SUBCONTRACT, THE LAKDAWALA LAB AT EMORY UNIVERSITY WILL LEVERAGE OUR INFLUENZA TRANSMISSION AND PATHOGENESIS EXPERTISE TO ASSIST IN MULTIPLE PROJECTS. WE USE OUR EXTENSIVE KNOWLEDGE OF VIRAL PROPERTIES THAT PROMOTE AIRBORNE TRANSMISSION OF INFLUENZA VIRUSES TO CHARACTERIZE EMERGING ZOONOTIC STRAINS EACH YEAR. OUR SPECIFIC STATEMENT OF WORK FOR EACH ELEMENT OF THE CEIRR APPLICATION IS DETAILED BELOW. REQUIRED #3: INFLUENZA SURVEILLANCE, RISK ASSESSMENT AND RESPONSE TASKS: 1. ASSESS THE REPLICATION OF EMERGING SWINE AND AVIAN VIRUSES IN PRIMARY HUMAN BRONCHIAL EPITHELIAL CELLS. 2. ASSIST IN MOLECULAR CHARACTERIZATION OF EMERGING SWINE AND AVIAN VIRUSES. REQUIRED #4: PRE-PANDEMIC AND PANDEMIC RESPONSE TASKS: 1. PERFORM FERRET PATHOGENESIS STUDIES FOR 1-3 INFLUENZA VIRUSES PER YEAR. (UP TO 12 ANIMALS PER YEAR) 2. PERFORM FERRET AIRBORNE TRANSMISSION STUDIES IN NAÏVE ANIMALS FOR 1-3 VIRUSES PER YEAR. (24 ANIMALS PER YEAR) 3. ASSESS TRANSMISSIBILITY OF EMERGING VIRUSES IN FERRETS WITH PRE-EXISTING IMMUNITY. (16 ANIMALS PER YEAR) 4. PERFORM MOLECULAR CHARACTERIZATION OF THESE VIRUSES TO ASSESS GROWTH IN PRIMARY HUMAN AIRWAY CELLS, STABILITY IN SIMULATED EXPELLED DROPLETS, RECEPTOR AND CELL TROPISM, AND NA ACTIVITY. REQUIRED #5: PATHOGENESIS AND IMMUNE RESPONSE RESEARCH (PROJECT 2: IMMUNITY CHANGING OVER TIME). TASKS: 1. PERFORM FERRET STUDIES TO ASSESS IMMUNE RESPONSES TO VACCINATION IN THE CONTEXT OF PRE-EXISTING IMMUNITY. (8 ANIMALS PER YEAR) 2. PERFORM FERRET STUDIES TO DEFINE THE LONGEVITY OF ANTIBODY RESPONSES IN THE FERRET MODEL (4 ANIMALS PER YEAR)”
• UNIVERSITY OF DAYTON

  UEI V62NC51F7YV1

  $690K

  Subcontractor to this prime · 1 sub-award · latest Jul 8, 2024

  • Department of the Air Force
  • “ENGINEERING SERVICES IN SUPPORT OF THE PRIME”
• VANDERBILT UNIVERSITY MEDICAL CENTER

  UEI GYLUH9UXHDX5

  $535K

  Subcontractor to this prime · 1 sub-award · latest Aug 12, 2024

  • Centers for Disease Control and Prevention
  • “IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2”
• BIOFIRE DEFENSE LLC

  UEI NHMDGM122546

  $465K

  Subcontractor to this prime · 3 sub-awards · latest Jun 30, 2026

  • Office of Assistant Secretary for Preparedness and Response
  • “CLINICAL PILOT STUDY”
  • “PIVOTAL CLINICAL STUDY”
  • “PILOT CLINICAL STUDY”
• UNIVERSITY OF ALABAMA AT BIRMINGHAM

  UEI YND4PLMC9AN7

  $406.6K

  Subcontractor to this prime · 1 sub-award · latest Aug 22, 2025

  • National Institutes of Health
  • “PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS.”
• TRIAD NATIONAL SECURITY, LLC

  UEI X7WUS5LRBQU3

  $350K

  Subcontractor to this prime · 1 sub-award · latest Jun 10, 2025

  • Department of Energy
  • “EMORY UNIVERSITY-STAND ALONE-ITEM LEVEL-R AND D”
• THE LELAND STANFORD JUNIOR UNIVERSITY

  UEI HJD6G4D6TJY5

  $227.5K

  Subcontractor to this prime · 1 sub-award · latest Aug 15, 2025

  • National Institutes of Health
  • “THE SUTHAR LABORATORY WILL COMPLETE THE SARS-COV-2 MOUSE CHALLENGE AND LIVE VIRUS NEUTRALIZATION ASSAYS TO COMPARE RESPONSES ACROSS ADJUVANTED VACCINE DATASETS AS DESCRIBED IN THE CONTRACT PROPOSAL.”

• UNIVERSITY OF ILLINOIS

  UEI Y8CWNJRCNN91 · not in the directory yet

  $2.1M

  Subcontracted by this company · 3 sub-awards · latest Nov 26, 2024

  • National Institutes of Health
  • “EMORY CEIRR”
• THE PENNSYLVANIA STATE UNIVERSITY

  UEI NPM2J7MSCF61

  $1.7M

  Subcontracted by this company · 3 sub-awards · latest Feb 10, 2026

  • National Institutes of Health
  • “EMORY CEIRR”

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.